GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (OTCPK:EAPIF) » Definitions » Beginning Cash Position

EAPIF (Euroapi) Beginning Cash Position : $295.9 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi Beginning Cash Position?

Euroapi's Beginning Cash Position for the quarter that ended in Dec. 2024 was $295.9 Mil.

Euroapi's quarterly Beginning Cash Position declined from Dec. 2023 ($62.2 Mil) to Jun. 2024 ($37.2 Mil) but then increased from Jun. 2024 ($37.2 Mil) to Dec. 2024 ($295.9 Mil).

Euroapi's annual Beginning Cash Position increased from Dec. 2022 ($10.9 Mil) to Dec. 2023 ($81.2 Mil) but then declined from Dec. 2023 ($81.2 Mil) to Dec. 2024 ($36.0 Mil).


Euroapi Beginning Cash Position Historical Data

The historical data trend for Euroapi's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi Beginning Cash Position Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial - 0.11 10.91 81.24 36.02

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.03 80.72 62.16 37.24 295.92

Euroapi Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Euroapi Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Euroapi's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroapi Business Description

Traded in Other Exchanges
Address
15 rue Traversiere, Paris, FRA, 75012
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers. Geographically, the company generates maximum revenue from Europe, followed by North America, Asia-Pacific, and the Rest of the world.